Anaheim, CA, United States
Preferred Pharmaceuticals, Inc. recalls
33 recalls recorded since 2018, most recently on 28 September 2026. 11 are listed as ongoing. Status and classification are as published by the FDA.
Recalls33
Ongoing (FDA)11
Terminated or completed22
Class I (FDA)0
Ongoing Class II Drugs
- Recall started
- 28 September 2026
- Reason
- Failed Content Uniformity Specifications
- Distribution
- USA Nationwide
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0013-2027
- Lidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro Pharmaceuticals U.S.A., Inc., Prod# (NDC): 68788-7865-05
Ongoing Class II Drugs
- Recall started
- 25 March 2026
- Reason
- Lack of Assurance of Sterility
- Distribution
- Nationwide within the United States
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0443-2026
- Artificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1%), 0.5 oz bottles, Mfg: Geri-Care; Brooklyn, New York NDC 68788-7266-0
Ongoing Class II Drugs
- Recall started
- 17 November 2025
- Reason
- Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
- Distribution
- Natinowide in the USA
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0239-2026
- Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferred Pharmaceuticals NDC 68788-8666-01
Ongoing Class II Drugs
- Recall started
- 18 April 2025
- Reason
- cGMP Deviations
- Distribution
- Nationwide in the US
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0391-2025
- Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited, NDC 68788-8685-03.
Ongoing Class II Drugs
- Recall started
- 8 August 2024
- Reason
- Failed Impurities/Degradation Specifications - at 18-month Stability testing
- Distribution
- CA and NV
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0647-2024
- Ibuprofen Tablets, USP 400mg, Generic for Motrin, Pkg Size: 30 tablets per bottle, Mfg: Dr. Reddy's Laboratories, Louisiana, Shreveport, NDC 68788-9110-03.
Ongoing Class II Drugs
- Recall started
- 10 May 2024
- Reason
- CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
- Distribution
- Product distributed to CA, FL, OK, KS and CT
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0505-2024
- Duloxetine Delayed-Release Cap USP 30mg, 30-count bottle, Rx only, Preferred Pharmaceutcals, Inc., NDC 68788-9301-03
Ongoing Class II Drugs
- Recall started
- 26 June 2023
- Reason
- Failed Stability Specifications
- Distribution
- Nationwide within the United States
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0894-2023
- Tizanidine Hydrochloride Tablet 4mg, packaged in a) 20 count-bottles (NDC 68788-7781-2), b)30-count bottles (NDC: 68788-7781-3), c) 60-count bottles, (NDC: 68788-7781-6), d) 90-count bottles (NDC: 68788-7781-9), e) 120-c
Terminated Class II Drugs
- Recall started
- 27 March 2023
- Terminated
- 24 October 2023
- Reason
- CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.
- Distribution
- Nationwide in the USA
- Initiated
- Voluntary: Firm initiated
- Recall numbers
- D-0504-2023, D-0506-2023, D-0505-2023
- Alprazolam Tab, USP 0.25mg, (CIV), 30-count bottle, Rx Only, Preferred Pharmaceuticals, Inc. Manufactured by: Breckenridge Pharmaceuticals, Inc., Boca Raton, FL. Ins:NDC 68788-7594-3
- Alprazolam Tab, USP 1mg, (CIV), packaged in: a) 30-count bottle (NDC 68788-7596-3), b) 60-count bottle (NDC68788-7596-6); Rx Only, Preferred Pharmaceuticals, Inc. Manufactured by: Breckenridge Pharmaceuticals, Inc., Boca
- Alprazolam Tab, USP 0.5mg, (CIV), packaged in: a) 30-count bottle (NDC 68788-7595-3), b) 60-count bottle (NDC 68788-7595-6), c) 90-count bottle (NDC 68788-7595-9); Rx Only, Preferred Pharmaceuticals, Inc. Manufactured by
Ongoing Class II Drugs
- Recall started
- 23 March 2023
- Reason
- cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
- Distribution
- USA Nationwide
- Initiated
- Voluntary: Firm initiated
- Recall numbers
- D-0515-2023, D-0527-2023, D-0511-2023, D-0523-2023, D-0520-2023, D-0526-2023, D-0518-2023, D-0512-2023, D-0521-2023, D-0522-2023, D-0517-2023, D-0524-2023 and 5 more
- Doxazosin Tablets, USP, 4 mg, 100-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7149-1
- Glimepiride Tablets USP, 4 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-8066-9
- Atorvastatin Calcium Tablets, USP, 10 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7630-9
- Simvastatin Tablets, USP, 80 mg, 90-count bottle, Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703, NDC 68788-9429-9
- Rosuvastatin Tablets, USP, 5mg, 30-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7971-3
- Tadalafil Tablets, USP, 20 mg, 7-count bottle, Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703, NDC 68788-8153-7
- Montelukast Sodium Tablets, USP, 10 mg, packaged in: a) 30-count bottle (NDC 68788-9438-3); b) 60-count bottle (NDC 68788-9438-6); c) 90-count bottle (NDC 68788-9438-9), Rx only, Manufactured: Accord Healthcare, Inc., Du
- Atorvastatin Calcium Tablets, USP, 20 mg, packaged in: a) 90-count bottle (NDC 68788-7631-9); b) 30-count bottle (NDC 68788-7631-3), Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703
- and 9 more product lines
Terminated Class II Drugs
- Recall started
- 16 January 2023
- Terminated
- 14 April 2023
- Reason
- Presence of Foreign Substance: manufacturer recalled this re-packaged product due to reports of a small piece of green plastic embedded in the crack towards the edge of the tablet.
- Distribution
- IN
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0173-2023
- Allopurinol Tablets 100mg, USP, 90-count bottles, Rx Only, 90, Mfg: Accord Healthcare, Inc; Durham, NC, PREFERRED Pharmaceuticals, Inc., The Physician's Solution, Prod#: 68788-7383-09.
Terminated Class II Drugs
- Recall started
- 3 May 2022
- Terminated
- 21 September 2022
- Reason
- CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
- Distribution
- Within the U.S in FL and CA.
- Initiated
- Voluntary: Firm initiated
- Recall numbers
- D-0891-2022, D-0892-2022
- Losartan Potassium & HCTZ Tablets 50mg/12.5 mg, hydrochlorothiazide USP 12.5, Pkg Size: 90, NDC: 68788-7758-09.
- Losartan Potassium & HCTZ Tablets 50mg/12.5 mg, hydrochlorothiazide USP 12.5 mg, Pkg Size: 30, NDC: 68788-7758-03.
Terminated Class II Drugs
- Recall started
- 12 April 2022
- Terminated
- 22 September 2022
- Reason
- CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.
- Distribution
- Nationwide within the U.S to CA, IN and FL.
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0789-2022
- Losartan Potassium Tab. USP 50mg, Pkg Size: 30, Mfg: Lupin Pharmaceuticals, Inc., Preferred Pharmaceuticals, Inc.
Terminated Class II Drugs
- Recall started
- 28 March 2022
- Terminated
- 10 May 2022
- Reason
- Out of specification results observed in dissolution during long term stability testing.
- Distribution
- Nationwide in the USA and CA.
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0769-2022
- Preferred Pharmaceuticals, Inc. The Physician's Solution., Lansoprazole Delayed-Release Capsules, 15mg, Generic for Prevacid, 90-Count Bottle, Manufacturer: Dr Reddy's Laboratories Limited, NDC 68788-6390-09
Terminated Class II Drugs
- Recall started
- 24 March 2022
- Terminated
- 17 November 2023
- Reason
- CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.
- Distribution
- Product distributed in California and Florida.
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0771-2022
- Econazole Nitrate Cream, 1%, Generic for Spectazole, 30 gm tube, Rx Only, Preferred Pharmaceuticals, Inc., The Physican's Solution, Mfg: Teligent Pharma, Inc., NDC 68788-7406-03
Terminated Class II Drugs
- Recall started
- 24 March 2022
- Terminated
- 25 October 2023
- Reason
- CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc. is discontinuing its stability study program.
- Distribution
- Nationwide within the USA.
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0773-2022
- Diclofenac Sodium Topical Solution 1.5% w/w, Generic for Pennsaid, 150 ml bottle, Rx Only, Mfg: Sola Pharmaceutical, Preferred Pharmaceuticals, Inc., The Physicians Solutions, NDC 68788-7918-01
Terminated Class II Drugs
- Recall started
- 23 March 2022
- Terminated
- 4 May 2023
- Reason
- CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc. is discontinuing its stability study program.
- Distribution
- IL
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0768-2022
- Clobetasol Propionate Lotion 0.05%, Generic for Temovate, 118 mL bottle, Rx Only, Mfg: Teligent Pharma, Inc., PREFERRED Pharmaceuticals, Inc., The Physician's Solution, NDC 68788-7768-01
Terminated Class II Drugs
- Recall started
- 22 February 2022
- Terminated
- 5 May 2023
- Reason
- CGMP deviations
- Distribution
- Nationwide in the USA.
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0642-2022
- Alprazolam Tablets, USP 1mg, Generic for Xanax, Pkg Size: a) 30 tablets per bottle, NDC: 68788-6381-03, b) 60 tablets per bottle, NDC: 68788-6381-06, c) 90 tablets per bottle, NDC: 68788-6381-09, Mfg: Par Pharmaceutical.
Ongoing Class II Drugs
- Recall started
- 29 November 2021
- Reason
- Defective container: Out of specification for container integrity leading to bottles leaking.
- Distribution
- Distributed to 5 physician consignees located in the following states: CT, FL, and KS.
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0278-2022
- Diclofenac Sodium Topical Solution, 1.5% w/w, packaged in 150 mL bottles, Rx only, Mfg: SOLA Pharmaceuticals Preferred Pharmaceuticals, Inc., NDC 68788-7707-01
Ongoing Class II Drugs
- Recall started
- 28 April 2021
- Reason
- CMGP Deviations: Presence of NDMA impurity detected in product and exceed the Acceptable Daily Intake Limit (ADI) of 96ng/day.
- Distribution
- Distributed to two physician consignees located in FL.
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0385-2021
- Preferred Pharmaceuticals Inc., Metformin HCl, Extended Release Tab. USP 500 mg, Generic for Glucophage XR, Rx Only, Pkg Size: 100, Mfg: Time-Cap Labs Inc.; Farmingdale NY, NDC #: 68788-6932-1
Ongoing Class II Drugs
- Recall started
- 12 April 2021
- Reason
- Failed Impurities/degradation specifications: Repackager recall due to Out of Specification detected by manufacturer for Individual Unidentified Impurity found during related substance test analysis of Cephalexin
- Distribution
- recalled product was distributed to three physicians located CA
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0342-2021
- Cephalexin for Oral Suspension, Generic for Keflex, USP, Powder for Oral Suspension, 250 mg/5mL, Pkg Size 100, Rx only, Repackaged by Preferred Pharmaceuticals, Inc., Mfg: Ascend Laboratories, LLC, NDC #: 68788-7529-1,
Terminated Class II Drugs
- Recall started
- 1 November 2020
- Terminated
- 20 May 2024
- Reason
- CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.
- Distribution
- Distributed to two physician's offices located in FL.
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0077-2021
- Metformin HCl Extended Release Tablets USP 500 mg, Generic for : Glucophage XR, Pkg Size 100, Mfg: Time-Cap Labs, Inc.; Farmingdale, NY, NDC #: 68788-6932-1, Preferred Pharmaceuticals, Inc.
Terminated Class II Drugs
- Recall started
- 2 September 2020
- Terminated
- 25 April 2024
- Reason
- CGMP Deviations
- Distribution
- Repackaged tablets sold to three physicians located in CA and GA.
- Initiated
- Voluntary: Firm initiated
- Recall numbers
- D-1623-2020, D-1621-2020, D-1624-2020, D-1622-2020
- Nature-Throid, 1 Grain, 65 mg (Thyroid U.S.P. 1 gr. (65mg)/Liothyronine (T3) 9mcg/Levothyroxine (T4) 38mcg, packaged in a) 90-count bottles (NDC 68788-7604-09), b) 100-count tablets (NDC 68788-7604-01), Rx Only, Mfg: RLC
- Nature-Throid, 1/2 Grain, 32.5 mg (Thyroid U.S.P. 1/2 gr. (32.5 mg)/Liothyronine (T3) 4.5mcg/Levothyroxine (T4) 19mch, 100-count tablets, Rx Only, Mfg: RLC Labs; Cave Creek, AZ, Preferred Pharmaceuticals, Inc. NDC 68788-
- Nature-Throid, 1.5 Grain, (97.5 mg), (Thyroid U.S.P. 1.5 gr. (97.5mg)/Liothyronine (T3) 13.5mcg/Levothyroxine (T4) 57mcg, 90-count bottles, Rx Only, Mfg: RLC Labs; Cave Creek, AZ, Preferred Pharmaceuticals, Inc. NDC 6878
- Nature-Throid, 3/4 Grain (48.75 mg) Thyroid U.S.P. 3/4 gr. (48.75 mg)/Liothyronine (T3) 6.75mcg/Levothyroxine (T4) 28.5mcg, 90-count tablets, Rx Only, Mfg: RLC Labs; Cave Creek, AZ, Preferred Pharmaceuticals, Inc. NDC 68
Terminated Class II Drugs
- Recall started
- 1 July 2020
- Terminated
- 17 April 2024
- Reason
- CGMP Deviations: Contract Manufacturing Organization (CMO) misplaced/lost batch records and test results for the recalled batch.
- Distribution
- Nationwide within the U.S.
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-1390-2020
- Lidothol Patch, Lidocaine 4.5% & Menthol 5%, In each patch: lidocaine 4.5% topical anesthetic, menthol 5% topical analgesic, Pkg Size 15 patches per box, Insurance NDC: 53225-1025-01, Mfg: Terrain Pharmaceuticals; Reno,
Terminated Class II Drugs
- Recall started
- 17 June 2020
- Terminated
- 21 March 2024
- Reason
- CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.
- Distribution
- Product was distributed to two medical clinics located in FL.
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-1364-2020
- Metformin HCl Extended Release Tablets, USP, 500 mg, Generic for Glucophage XR, Pkg Size 100, Mfg: Time-Cap, Labs Inc., Farmingdale, NY, Preferred Pharmaceuticals, Anaheim, CA NDC: 68788-6932-01
Terminated Class II Drugs
- Recall started
- 7 January 2020
- Terminated
- 14 December 2023
- Reason
- CGMP Deviations: Presence of NDMA impurity detected in product.
- Distribution
- Distribution to physicians in the following states: AL, AZ, CA, FL, GA, IN, and SC
- Initiated
- Voluntary: Firm initiated
- Recall numbers
- D-0797-2020, D-0796-2020
- Preferred Pharmaceuticals, Inc, Ranitidine Tablets, 300 mg, Rx Only, a) 14 count bottles (NDC: 68788-6382-1), b) 30 count bottles (NDC: 68788-6382-3), c) 90 count bottles (NDC: 68788-6382-9), d) 100 count bottles (NDC: 6
- Preferred Pharmaceuticals, Inc, Ranitidine Tablets, 150 mg, a) 30 count bottles (NDC: 68788-7388-3), b) 60 count bottles (NDC: 68788-7388-6), c) 90 count bottles (NDC: 68788-7388-9), d) 100 count bottles (NDC: 68788-7388
Terminated Class II Drugs
- Recall started
- 2 December 2019
- Terminated
- 9 May 2023
- Reason
- CGMP Deviations: Presence of NDMA impurity detected in product.
- Distribution
- CA, FL
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0617-2020
- Ranitidine Tablets, USP 150 mg, OTC, a.) 30 count bottle (NDC 68788-7078-03), b.) 60 count bottle (NDC 68788-7078-06), Mfg: Amneal Pharmaceuticals
Terminated Class II Drugs
- Recall started
- 21 November 2019
- Terminated
- 11 May 2023
- Reason
- Presence of foreign substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.
- Distribution
- CA, FL, IL
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0531-2020
- Ibuprofen Oral Suspension USP, 100 mg/5mL, 4 fl.oz. 118 mL, Rx only, Preferred Pharmaceuticals, Inc., Anaheim, CA. Mfg: Taro Pharm.; Hawthorne, NY; NDC 68788-7268-01
Terminated Class II Drugs
- Recall started
- 29 August 2019
- Terminated
- 24 April 2023
- Reason
- Failed Impurities/Degradation Specifications
- Distribution
- Product was distributed to 1 physician in Gainesville Florida.
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-1877-2019
- Fexofenadine HCl Tablets, 180 mg, Pkg Size 90, Mfg: Aurohealth LLC, Repackaged by Preferred Pharmaceuticals, Inc., Anaheim, CA, NDC #: 68788-6848-09
Terminated Class II Drugs
- Recall started
- 18 July 2019
- Terminated
- 24 April 2023
- Reason
- CGMPs Deviations: Insufficient Quality Assurance controls over critical systems in the manufacturing facility.
- Distribution
- CA, FL
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-1491-2019
- Neomycin Sulfate 3.5 mg/Polymyxin B Sulfate 10,000 units/Dexamethasone 1 mg Ophthalmic Ointment, Pkg Size 3 g Tube, Generic for: Maxitrol, For External Use Only, Rx only, Mfg: Paddock Laboratories, LLC, Preferred Pharma
Terminated Class II Drugs
- Recall started
- 10 June 2019
- Terminated
- 3 April 2023
- Reason
- CGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).
- Distribution
- Distribution was made to CA and FL.
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-1410-2019
- Robafen DM, Generic for Robitussin DM, In each teaspoonful (5mL): Dextromethorphan HBr, USP 10mg,/Guaifenesin, USP 100mg, 118mL (4oz) bottle, Manufactured for Preferred Pharmaceuticals, Inc., Anaheim, CA 92807 by Major P
Terminated Class II Drugs
- Recall started
- 30 April 2019
- Terminated
- 3 April 2023
- Reason
- CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer
- Distribution
- CA, GA, IN. No DOD/VA accounts. No foreign accounts.
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-1281-2019
- Losartan Potassium Tab. USP 50mg, a) 30 count bottle (NDC 68788-0048-03) and b) 90 count bottle (NDC 68788-0048-09), Rx only, Preferred Pharmaceuticals, Inc., Anaheim, CA, Mfg: Torrent Pharma Inc., Basking Ridge, NJ
Terminated Class II Drugs
- Recall started
- 6 March 2019
- Terminated
- 30 March 2023
- Reason
- CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) was identified.
- Distribution
- California, Georgia, Indiana
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-1051-2019
- Losartan Potassium Tablets, USP, 50 mg, a) 30-count bottle (NDC: 68788-0048-03), b) 90-count bottle (NDC: 68788-0048-09), Rx Only, Mfg: Torrent Pharma Inc. Basking Ridge, NJ. Relabeled by: Preferred Pharmaceuticals, Inc.
Terminated Class II Drugs
- Recall started
- 15 August 2018
- Terminated
- 18 January 2019
- Reason
- CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
- Distribution
- Products were distributed to one distributor in Alabama who may have further distributed the product to the consumer level.
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-1107-2018
- Valsartan Tablets USP 320 mg, 90-count, plastic child resistant bottle, Rx Only, Preferred Pharmaceuticals, Inc., 1250 N. Lakeview Ave., Suite O, Anaheim, CA 92807, NDC 68788-6882-9
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.